Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
Clinical trial NCT06194929 · RECRUITING
Trial details
- NCT number
- NCT06194929
- Sponsor
- University of Utah
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-20
- Primary completion
- 2028-01-15
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.